α-Internexin in the diagnosis of oligodendroglial tumors and association with 1p/19q status

Journal of Neuropathology and Experimental Neurology

Volumn 70, Issue 11, 2011, Pages 970-978

  Eigenbrod, Sabina ^a   Roeber, Sigrun ^a   Thon, Niklas ^a   Giese, Armin ^a   Krieger, Anna ^a   Grasbon Frodl, Eva ^a   Egensperger, Rupert ^a   Tonn, Jörg Christian ^a   Kreth, Friedrich Wilhelm ^a   Kretzschmar, Hans A ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Internexin; 1p 19q; Diagnostic marker; Glioma; LOH; Oligodendroglioma; Proliferation

Indexed keywords

ALPHA INTERNEXIN;

ARTICLE; CANCER GRADING; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

BRAIN NEOPLASMS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 19; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MICROSATELLITE REPEATS; OLIGODENDROGLIOMA; STATISTICS AS TOPIC;

EID: 80054924624     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3182333ef5     Document Type: Article

References (25)

1. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114: 97-109 (Pubitemid 47103521)
2. Cairncross G, Berkey B, Shaw E, et al. Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 2006;24:2707-14 (Pubitemid 46630566)
3. Jenkins RB, Blair H, Ballman KV, et al. A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 2006;66:9852-61 (Pubitemid 44672036)
4. Smith JS, Perry A, Borell TJ, et al. Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 2000;18:636-45 (Pubitemid 30078545)
5. Wick W, Hartmann C, Engel C, et al. NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 2009;27: 5874-80
6. Ducray F, Criniere E, Idbaih A, et al. α-Internexin expression identifies 1p/19q codeleted gliomas. Neurology 2009;72:156-61
7. Thon N, Eigenbrod S, Grasbon-Frodl EM, et al. Novel molecular stereotactic biopsy procedures reveal intratumoral homogeneity of loss of heterozygosity of 1p/19q and TP53 mutations in World Health Organization grade II gliomas. J Neuropathol Exp Neurol 2009;68:1219-28
8. Hartmann C, Mueller W, Lass U, et al. Molecular genetic analysis of oligodendroglial tumors. J Neuropathol Exp Neurol 2005;64:10-14 (Pubitemid 40189474)
9. Idbaih A, Marie Y, Pierron G, et al. Two types of chromosome 1p losses with opposite significance in gliomas. Ann Neurol 2005;58:483-87 (Pubitemid 41266639)
10. Cairncross JG, Ueki K, Zlatescu MC, et al. Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 1998;90:1473-79 (Pubitemid 28482012)
11. Iuchi T, Namba H, Iwadate Y, et al. Identification of the small interstitial deletion at chromosome band 1p34-p35 and its association with poor outcome in oligodendroglial tumors. Genes Chromosomes Cancer 2002; 35:170-75 (Pubitemid 34919974)
12. Bello MJ, Leone PE, Vaquero J, et al. Allelic loss at 1p and 19q frequently occurs in association and may represent early oncogenic events in oligodendroglial tumors. Int J Cancer 1995;64:207-10
13. Jeuken JW, Sprenger SH, Wesseling P, et al. Identification of subgroups of high-grade oligodendroglial tumors by comparative genomic hybridization. J Neuropathol Exp Neurol 1999;58:606-12 (Pubitemid 29264940)
14. Maintz D, Fiedler K, Koopmann J, et al. Molecular genetic evidence for subtypes of oligoastrocytomas. J Neuropathol Exp Neurol 1997;56: 1098-104 (Pubitemid 27430471)
15. Reifenberger J, Reifenberger G, Liu L, et al. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am J Pathol 1994;145:1175-90 (Pubitemid 24345665)
16. Kraus JA, Koopmann J, Kaskel P, et al. Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma. J Neuropathol Exp Neurol 1995;54:91-95
17. Ikota H, Kinjo S, Yokoo H, et al. Systematic immunohistochemical profiling of 378 brain tumors with 37 antibodies using tissue microarray technology. Acta Neuropathol 2006;111:475-82
18. Torp SH. Diagnostic and prognostic role of Ki67 immunostaining in human astrocytomas using four different antibodies. Clin Neuropathol 2002;21:252-57 (Pubitemid 35397967)
19. Fliegner KH, Kaplan MP, Wood TL, et al. Expression of the gene for the neuronal intermediate filament protein alpha-internexin coincides with the onset of neuronal differentiation in the developing rat nervous system. J Comp Neurol 1994;342:161-73 (Pubitemid 24100124)
20. Kaplan MP, Chin SS, Fliegner KH, et al. alpha-Internexin, a novel neuronal intermediate filament protein, precedes the low molecular weight neurofilament protein (NF-L) in the developing rat brain. J Neurosci 1990;10:2735-48
21. Chien CL, Liu TC, Ho CL, et al. Overexpression of neuronal intermediate filament protein alpha-internexin in PC12 cells. J Neurosci Res 2005;80: 693-706
22. McGraw TS, Mickle JP, Shaw G, et al. Axonally transported peripheral signals regulate alpha-internexin expression in regenerating motoneurons. J Neurosci 2002;22:4955-63 (Pubitemid 37465610)
23. Lu QR, Sun T, Zhu Z, et al. Common developmental requirement for Olig function indicates a motor neuron/oligodendrocyte connection. Cell 2002;109:75-86 (Pubitemid 34327518)
24. Ohnishi A, Sawa H, Tsuda M, et al. Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas. J Neuropathol Exp Neurol 2003;62:1052-59 (Pubitemid 37229534)
25. Ho CL, Liem RK. Intermediate filaments in the nervous system: Implications in cancer. Cancer Metastasis Rev 1996;15:483-97 (Pubitemid 27067167)